(Q33960223)

30 July 2017

9 references

12 March 2019

13 March 2019

17 June 2019

30 June 2019

11 November 2019

20 November 2019

24 July 2020

12 September 2020

26 October 2020

Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review (English)

1 reference

systemic lupus erythematosus

30 July 2017

main subject

9 references

12 March 2019

13 March 2019

17 June 2019

30 June 2019

11 November 2019

20 November 2019

24 July 2020

12 September 2020

26 October 2020

1 reference

11 November 2019

1 reference

20 November 2019

1 reference

24 July 2020

1 reference

12 September 2020

immunosuppressive drug

1 reference

26 October 2020

Kam Hon Yoon

1

1 reference

30 July 2017

language of work or name

1 reference

28 June 2010

10 references

Journal of Biomedicine and Biotechnology

30 July 2017

12 March 2019

13 March 2019

17 June 2019

30 June 2019

11 November 2019

20 November 2019

24 July 2020

12 September 2020

26 October 2020

10 references

30 July 2017

12 March 2019

13 March 2019

17 June 2019

30 June 2019

11 November 2019

20 November 2019

24 July 2020

12 September 2020

26 October 2020

2010

1 reference

30 July 2017

page(s)

686480

1 reference

Creative Commons Attribution 3.0 Unported

30 July 2017

copyright license

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

Successful treatment of class V+IV lupus nephritis with multitarget therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

The role of interleukin-10 in systemic lupus erythematosus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus

5 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Predominant inhibition of Th1 cytokines in New Zealand black/white F1 mice treated with FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Multitarget therapy of lupus nephritis: base hit or home run?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2010%2F686480

Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

Tacrolimus therapy for systemic lupus erythematosus without renal involvement: a preliminary retrospective study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

Cytokine production, serum levels and disease activity in systemic lupus erythematosus

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896715

Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus

29 October 2018

1 reference

12 December 2020

Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice

1 reference

12 December 2020

New pieces to the SLE cytokine puzzle

1 reference

12 December 2020

Good response of membranous lupus nephritis to tacrolimus

1 reference

12 December 2020

A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade

1 reference

12 December 2020

Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.

1 reference

12 December 2020

Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center

1 reference

12 December 2020

Identifiers

DOI

10.1155/2010/686480

1 reference

30 July 2017

1 reference

30 July 2017

1 reference